Potential of hybrid 18F-fluorocholine PET/MRI for prostate cancer imaging
暂无分享,去创建一个
Osman Ratib | Christophe Iselin | Jean-Paul Vallée | Max Scheffler | O. Ratib | J. Vallée | C. Iselin | O. Rager | M. Pusztaszeri | Olivier Rager | M. Lord | Martin Lord | M. Scheffler | Thomas de Perrot | Marc Pusztaszeri | T. Perrot
[1] Volker Schmid,et al. Quantitative Analysis of Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging for Oncology in R , 2011 .
[2] S. Ziegler,et al. Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[3] J. Machan,et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.
[4] R. Miralbell,et al. Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[5] S. Y. Park,et al. Diffusion-Weighted Imaging of a Prostate Cancer Xenograft Model Seen on a 7 Tesla Animal MR Scanner: Comparison of ADC Values and Pathologic Findings , 2011, Korean journal of radiology.
[6] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[7] Mario Marengo,et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] M. Schouten,et al. Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.
[9] Daniel U. Campos-Delgado,et al. Non-rigid multimodal image registration based on local variability measures and optical flow , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[10] S. Verma,et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.
[11] J. Pruim,et al. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[12] Karsten Tabelow,et al. Image analysis and statistical inference in neuroimaging with R , 2011, NeuroImage.
[13] F. Fazio,et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. , 2008, European urology.
[14] Cher Heng Tan,et al. Diffusion weighted imaging in prostate cancer , 2011, European Radiology.
[15] R. Günther,et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[16] R. Shah,et al. Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer , 2012, The Journal of Nuclear Medicine.
[17] F. Mottaghy,et al. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? , 2012, International journal of radiation oncology, biology, physics.
[18] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[19] A. Padhani. Integrating multiparametric prostate MRI into clinical practice , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.
[20] A. Ahmadian,et al. MRI-guided attenuation correction in whole-body PET/MR: assessment of the effect of bone attenuation , 2013, Annals of Nuclear Medicine.
[21] H. Zaidi,et al. Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence , 2008, Nuklearmedizin.
[22] M. Schwaiger,et al. The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[24] N. Rofsky,et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. , 2004, Radiology.
[25] E. Rostrup,et al. Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.
[26] T. Shiga,et al. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[27] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[28] Eveliina Arponen,et al. Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT. , 2012, European journal of radiology.
[29] C. Nanni,et al. Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy , 2009, Journal of Nuclear Medicine.
[30] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[31] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] J. Talbot,et al. 18F-choline PET/CT for initial staging of advanced prostate cancer. , 2006, AJR. American journal of roentgenology.
[33] P. Carroll,et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.
[34] Thomas Hambrock,et al. Initial Experience With Identifying High-Grade Prostate Cancer Using Diffusion-Weighted MR Imaging (DWI) in Patients With a Gleason Score ⩽3 + 3 = 6 Upon Schematic TRUS-Guided Biopsy: A Radical Prostatectomy Correlated Series , 2012, Investigative radiology.
[35] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[36] G. V. von Schulthess,et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. , 2005, Radiology.
[37] Takeshi Yoshikawa,et al. Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.
[38] F Fazio,et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. , 2003, The Journal of urology.
[39] H. Zaidi,et al. Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system , 2011, Physics in medicine and biology.
[40] A. Oto,et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. , 2011, AJR. American journal of roentgenology.
[41] Y. Liu,et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. , 2008, Clinical radiology.
[42] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[43] P. Waldenberger,et al. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. , 2010, Radiology.
[44] Gary P Liney,et al. Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.
[45] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[46] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[47] V. Khoo,et al. Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11 C-choline Positron , 2012 .